Identification And Binding Characterisation Of Peptide-Bearing Phages Towards Recombinant Protease (Ns6) Of Murine Norovirus by Soid, Nur Sakinah
 
 
IDENTIFICATION AND BINDING 
CHARACTERISATION OF PEPTIDE-BEARING 
PHAGES TOWARDS RECOMBINANT 




















UNIVERSITI SAINS MALAYSIA 
2019  
IDENTIFICATION AND BINDING 
CHARACTERISATION OF PEPTIDE-BEARING 
PHAGES TOWARDS RECOMBINANT 












Thesis submitted in fulfilment of the requirements  
for the degree of  

















I dedicate this thesis to those who are supporting me mainly  
my beloved father and mother 
Soid bin Mansor 
and 















In the name of Allah, the Most Gracious and the Most Merciful. 
 Acknowledging the dedicated efforts of those who gave me support and made 
my postgraduate studies a great experience, is a great pleasure for me. 
 Alhamdulillah, all praises and grateful to Allah, God the Almighty for giving 
me strength, patience, inspiration and opportunity to complete my Msc project. A lot 
of experiences and knowledge were gained along the way. 
 Throughout the most exciting in learning the practical aspect of this course, I 
would like to thank those who support me along the way this project being done. My 
greatest gratitude goes to my family especially my parents, husband and siblings for 
their moral support. To my family, I love all of you. 
 I also would like to express my sincere appreciation to my supervisor, Dr 
Muhammad Amir bin Yunus for his knowledge, guidance and encouragement towards 
the completion of my thesis. Special thanks to my co-supervisor Dr Ida Shazrina and 
Dr Kumitaa for their endless supervision throughout my study. In addition, great 
thanks for my lab mates Nalini, Nurul, Nithya, Khirun, Laina, Adam, Azali and Din 
who are together with me in the hardness and happiness throughout this project. Not 
to be forgotten, to all IPPT staffs especially laboratory staffs, En Zul and Pn Hikmah 
whom their assistant, direction and knowledge have directly contributed towards 
completing my thesis project.  
 Apart from that, I dedicate my appreciation to my beloved housemate (Fatin, 
Aida and Athirah) for always being with me during ups and downs and a very special 
thanks to all my postgraduate friends, for their friendship and useful discussions over 
the last three years. Thanks a lot from the deepest of my heart for those who have 
contributed directly or indirectly for my project.  
Last but not least, I would like to acknowledge Yayasan Khazanah who has 
supported me financially throughout my study year.  
 





TABLE OF CONTENT 
ACKNOWLEDGEMENT……………………………………………........ ii 
TABLE OF CONTENT………………………………………………........ iii 
LIST OF TABLES…………………………………………………………. viii 
LIST OF FIGURES………………………………………………………... x 
LIST OF ABBREVIATIONS……………………………………………... xii 




CHAPTER 1 : INTRODUCTION………………………………………... 1 
1.1 Research Overview…………………………………………………… 1 
1.2 Objectives of study………………………………………………......... 3 
 1.2.1 General objective……………………………………………. 3 
 1.2.2 Specific objectives…………………………………………... 3 
  
CHAPTER 2 : LITERATURE REVIEW………………………………... 4 
2.1 Gastroenteritis……………………………………………………........ 4 
2.2 Caliciviruses…………………………………………………………... 5 
 2.2.1 Classification and Taxonomy……………………………….. 6 
 2.2.2 Morphology and Genome Organisation of Caliciviruses…… 7 
2.3 Norovirus…………………………………………………………....... 8 
 2.3.1 Norovirus Genome Structure………………………………... 11 
  2.3.1(a) Norovirus Non-Structural Proteins………….......... 14 
  2.3.1(b) Norovirus Structural Proteins……………….......... 17 
 2.3.2 Virus Life Cycle……………………………………………... 19 
  2.3.2(a) Attachment and Entry……………………….......... 19 
  2.3.2(b) Translation of Viral Proteins……………………... 20 
  2.3.2(c) Genome Replication…………………………........ 23 
  2.3.2(d) Capsid Assembly and Virus Release……………... 25 
 2.3.3 Murine Norovirus…………………………………………… 26 
 2.3.4 NS6 Protease……………………………………………........ 28 
iv 
 
2.4 Antivirus………………………………………………………………. 33 
2.5 Phage Display………………………………………………………… 36 
2.6 Secondary and Tertiary Structure of Protein………………………….. 38 
2.7 Bioinformatics of Protein Ligand Interaction………………………… 40 
   
CHAPTER 3 : MATERIALS AND METHODS……………………........ 45 
3.1 List of Reagents/Chemicals………………………………………....... 45 
3.2 Plasmid Construction…………………………………………………. 52 
 3.2.1 Bioinformatics Tools……………………………………....... 52 
 3.2.2 Polymerase Chain Reaction (PCR) …………………………. 52 
 3.2.3 Site-Directed Mutagenesis…………………………………... 53 
 3.2.4 Agarose Gel Electrophoresis……………………………....... 54 
 3.2.5 Cloning………………………………………………………. 54 
 3.2.6 Restriction Enzyme Reaction………………………………... 54 
 3.2.7 Gel and PCR Purification…………………………………… 55 
 3.2.8 DNA Quantification…………………………………………. 56 
 3.2.9 Ligation Reaction……………………………………………. 56 
 3.2.10 Transformation………………………………………………. 56 
 3.2.11 Screening Positive Colonies………………………………… 57 
 3.2.12 Medium Scale Plasmid Preparation…………………………. 58 
 3.2.13 Analysis of Plasmid Preparation…………………………….. 59 
3.3 Protein Expression and Purification…………………………………... 60 
 3.3.1 Preparation of BL21 (DE3) Competent Cell……………....... 60 
 3.3.2 Transformation into BL21 (DE3) ………………………....... 60 
 3.3.3 Growth Curve of Transformed BL21 DE3 (+pCG1) ……….. 61 
 3.3.4 IPTG Induction……………………………………………… 61 
 3.3.5 Sodium Dedocyl Sulfate (SDS) polyacrylamide gel 
electrophoresis (PAGE) …………………………………….. 
62 
 3.3.6 Cell Lysis……………………………………………………. 63 
 3.3.7 Protein Purification………………………………………….. 63 
  3.3.7(a) Equilibration……………………..……………….. 63 
  3.3.7(b) Sample Application……………..………………... 63 
  3.3.7(c) Washing………………………..…………………. 64 
v 
 
  3.3.7(d) Elution…………………………..………………... 64 
 3.3.8 Determination of Protein Concentration…………………….. 64 
 3.3.9 Western Blot………………………………………………… 65 
3.4 Preparation and Optimisation for Peptide Phage Selection………....... 66 
 3.4.1 Quantification of Phage’s Host Bacterial Cell………………. 66 
  3.4.1(a) E. coli ER2738 Culture………...………………… 66 
  3.4.1(b) E. coli ER2738 Growth Curve and 
Quantification…………..………..……………….. 
66 
 3.4.2 Phage Titration………………………………………………. 67 
 3.4.3 Determination of Optimum Concentration of Protein to be 
Coated on Plate…………………………………………........ 
68 
3.5 Subtractive Screening of Peptide Phage Display Library against 
Target Protein……………………………………………..................... 
69 
 3.5.1 Panning against Streptavidin……………………………....... 69 
 3.5.2 Panning against C139A NS6 Protease…………………….. 71 
 3.5.3 Phage Titration………………………………………………. 71 
 3.5.4 Phage Amplification, Precipitation and Purification………... 71 
3.6 Isolation of Phage DNA………………………………………………. 72 
 3.6.1 Plaque Isolation and Amplification…………………………. 72 
 3.6.2 Phage DNA Extraction……………………………………… 72 
 3.6.3 PCR Amplification of DNA Insert from Phage Genome…… 73 
 3.6.4 Purification of PCR Amplicon………………………………. 73 
 3.6.5 DNA Sequencing Analysis………………………………….. 74 
3.7 Binding Affinity Assessment of Phage……………………………….. 74 
3.8 Bioinformatics Study…………………………………………………. 75 
 3.8.1 Prediction of Protein Structure……………………………… 75 
 3.8.2 Prediction of Selected Peptide Phage Binding Sites on 
C139A NS6 Protease………………………………………. 
75 
  
CHAPTER 4 : RESULTS……………………………................................. 77 
4.1 Recombinant MNV-1 C139A NS6 Production and Purification…… 77 
 4.1.1 Cloning of C139A NS6 Gene into Expression Plasmid..….. 77 
 4.1.2 Overexpression and Purification of MNV-1 C139A NS6…. 84 
vi 
 
4.2 Identification of Peptide Phage with Binding Capacity towards the 
Target Proteins ……………..…………….......................……………. 
87 
 4.2.1 Parameters Optimisation for Peptide Phage Selection …....... 87 
  4.2.1(a) Optimum Growth Time for E. coli ER2738 
Culture …………………………….….………….. 
87 
  4.2.1(b) Peptide Phage Concentration in the Ph.D-7 Phage 
Display Peptide Library Kit…..………………….. 
89 
  4.2.1(c) Determination of Optimum Concentration of 
Streptavidin to be Coated on Plate…..………........ 
89 
4.3 Peptide-phage with Binding Activity towards Streptavidin………….. 90 
 4.3.1 Panning of Peptide Phage Library against Streptavidin…….. 90 
 4.3.2 Identity of Peptide Sequence from Streptavidin-Binding 
Peptide Phage... …………………………………….............. 
92 
 4.3.3 Binding Kinetics of Selected Peptide Phage towards 
Streptavidin…………………………………………….......... 
94 
4.4 Peptide-phage with Binding Activity towards MNV-1 C139A NS6.. 95 
 4.4.1 Determination of Optimum Concentration of C139A NS6 
to be Coated on Plate………………………………………... 
95 
 4.4.2 Panning of Peptide Phage Library against C139A NS6…… 96 
 4.4.3 Identity of Peptide Sequence from C139A NS6-Binding 
Peptide Phage……………………………………...……….... 
97 
 4.4.4 Binding Kinetics of Selected Peptide Phage towards 
C139A NS6……..……………………………………......... 
103 
4.5 Structure Prediction C139A NS6 Protease ……………………......... 106 
4.6 Binding Simulation (Docking) of Selected Peptide Sequences 
towards C139A NS6……………………………………………........ 
108 
 4.6.1 Binding Simulation of 7-mer Peptide ADARYKS on 
C139A NS6…….…………………………………….......... 
108 
 4.6.2 Binding Simulation of 7-mer Peptide QTEKNPL on 
C139A NS6……..……………………………………......... 
110 
 4.6.3 Binding Simulation of 7-mer Peptide NSLKVLG on 
C139A NS6…….…………………………………….......... 
112 
    
vii 
 
CHAPTER 5 : DISCUSSION……………………………………............... 114 
5.1 Production of Recombinant C139A NS6…………………………… 114 
5.2 Parameters Optimisation for Peptide Phage Selection………………... 117 
 5.2.1 Optimum Growth Time for E. coli ER2738 Culture……....... 117 
 5.2.2 Peptide Phage Concentration in the Ph.D-7 Phage Display 
Peptide Library Kit………………………………………….. 
118 
 5.2.3 Optimum Concentration of Target Proteins on ELISA Plate.. 119 
5.3 Peptide Phage Library Panning against Streptavidin…………………. 119 
5.4 Binding Kinetics of Selected Peptide Phage towards Streptavidin........ 123 
5.5 Peptide Phage Library Panning against C139A NS6 Protein……….. 124 
5.6 Binding Kinetics of Selected Peptide Phage towards C139A NS6…. 128 
5.7 Prediction of Protein Interaction between Selected 7-mer Peptide 
Sequences and C139A NS6 Protein………………………………… 
130 
 5.7.1 Structure Prediction of C139A NS6 using I-TASSER…….. 130 




CHAPTER 6 : CONCLUSION & FUTURE RECOMMENDATIONS.. 134 
6.1 Conclusion Future Direction …………………………………………. 134 















LIST OF TABLES 
  Page 
Table 3.1 Bacterial strain and plasmid 45 
Table 3.2 Antibodies 46 
Table 3.3 Commercial kit 46 
Table 3.4 Bacterial culture media and antibiotics 47 
Table 3.5 Reagents 47 
Table 3.6 Chemicals 48 
Table 3.7 Consumables  49 
Table 3.8 List of Equipments 49 
Table 3.9 Recipe for preparation of reagents 50 
Table 3.10 List of Primers 51 
Table 3.11 PCR components 53 
Table 3.12 PCR condition for NS6 protease gene amplification 53 
Table 3.13 Components for GoTaq DNA polymerase 59 
Table 3.14 Resolving gel 62 
Table 3.15 Stacking gel 62 
Table 3.16 Standard BCA 65 








Table 4.2 The identified sequences from 20 single clone phages 94 
Table 4.3 Total number input phage, recovered phage (output 
phage), amplified phage and phage enrichment for each 





Table 4.4 DNA sequences analysis of 98 samples of C139A 
NS6 phage clones 
 
101 
Table 4.5 Maximum binding value, Bmax and dissociation 
constant, Kd of selected clones 
 
105 
Table 4.6 Peptide-receptor interactions between ADARYKS 
peptide and C139A NS6 receptor 
 
109 
Table 4.7 Peptide-receptor interactions between QTEKNPL 
peptide and C139A NS6 receptor 
 
111 
Table 4.8 Peptide-receptor interactions between NSLKVLG 







































LIST OF FIGURES 
  Page 




Figure 2.1(B) Schematic structure of capsid protein 
 
13 




Figure 2.3 Schematic diagram of protease cleavage  
 
31 




Figure 4.1(A) The schematic diagram of expression plasmid 
(pET26Ub: MNV 3D-His) 
 
79 
Figure 4.1(B) The schematic diagram of pT7:MNV3’Rz plasmid 
that contains the full genomic sequence of MNV-1 
 
79 
Figure 4.2 This schematic diagram of polymerase chain 




Figure 4.3 The PCR amplicons from 1st pair of primer 81 
Figure 4.4 The PCR amplicons from 2nd pair of primer 81 
Figure 4.5 The final PCR amplicon from 3rd pair of primer 82 
Figure 4.6 Product of restriction enzyme (SacII and BamHI) 








Figure 4.8 Growth curve of C139A NS6-His 85 
Figure 4.9 Expression of C139A NS6 protein 85 




Figure 4.11 Purified C139A NS6 protein 86 
xi 
 
Figure 4.12 Growth curve of E. coli ER 2738 88 
Figure 4.13 Optimum concentration of streptavidin and BSA 90 




Figure 4.15 PCR products from amplification using purified 
phage genomic DNA of single clones 
 
93 
Figure 4.16 Library insert sequences fused to the pIII major coat 
protein and located on the region between 2 
restriction sites  
 
93 
Figure 4.17 Binding kinetics illustrating the specificity and 
affinity of the peptide phage clone towards 
Streptavidin and BSA protein 
 
95 
Figure 4.18 Optimum Concentration of C139A NS6 to be 
Coated on Plate 
 
96 
Figure 4.19 PCR products from amplification using purified 
phage genomic DNA of single clones isolated from 
panning against C139A NS6 
 
99 
Figure 4.20 Percentage of hits of the identified peptides 
 
102 
Figure 4.21 Binding ability of selected peptide-bearing phage 
clones at phage concentration 2 X 011 pfu/ml 
towards different target protein 
 
104 
Figure 4.22 Binding kinetics of selected phage clones towards 
target protein C139A NS6 
 
105 
Figure 4.23 Schematic representation of protein structure 
 
107 
Figure 4.24 Predicted structure of ADARYKS peptide C139A 




Figure 4.25 Predicted structure of QTEKNPL peptide C139A 




Figure 4.26 Predicted structure of NSLKVLG peptide C139A 




Figure 5.1 Schematic representation of the expression plasmid 




LIST OF ABBREVIATIONS 
 
C139A NS6 active site mutant 
BCA Bicinchoninic Acid 
BSA Bovine serum albumin 
CDC Centre for Disease Control & Prevention 
cDNA complementary Deoxyribonucleic Acid 
CIP Calf alkaline phosphatase 
DNA Deoxyribonucleic acid 
ECL Enhanced Chemiluminescent 
EDTA Ehtylenediaminetetraacetic Acid 
eIFs Eukaryotic initiation factors 
ELISA Enzyme-linked Immnosorbent Assay 
EtBr Ethidium Bromide 
FCV Feline Calicivirus 
FUT 2 α-(1,2)-fucosyltransferase 
gRNA genomic RNA 
HBGAs histo-blood group antigens 
HCV Hepatitis C virus 
HPQ Histidine-Proline-Glutamine 
HRP Horseradish Peroxidase 
HuCv Human calicivirus 
HuNv Human norovirus 
IPTG Isopropyl β-D-1-Thiogalactopyranoside 
xiii 
 
LB Luria Bertani 
MNV Murine norovirus 
NCBI National Center for Biotechnology Information 
NV Norovirus 
OD Optical density 
ORF Open reading frame 
PBS Phosphate Buffer Saline 
PCR Polymerase Chain Reaction 
PEC Porcine enteric calicivirus 
PMO phosphorodiamidate morpholino oligomer 
PPMO peptide conjugated phosphorodiamidate morpholino oligomers 
PVDF polyvinylidene fluoride 
RAG 2 recombination activation gene 2 
RAW264.7 murine macrophage cell line 
RdRp RNA dependent RNA polymerase 
RNA Ribonucleic acid 
SDS sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sgRNA subgenomic RNA 
STAT-1 signal transducer and activation of transcription 1 
TBS tris buffered saline 
TBST tris buffered saline containing Tween 20 
TMB 3,3’5,5’-Tetramethylbenzidine 
UTR Untranslated region 
xiv 
 
VF1 Virulence factor 1 
VLP Viral-like particle 
VPg Viral protein linked genome 



























LIST OF SYMBOLS 
% Percentage 
> more than 









pfu plaque forming unit 
secs Seconds 
v/v volume per volume 













IDENTIFIKASI DAN PENCIRIAN PENGIKATAN FAJ PEPTIDA  





Jangkitan norovirus dianggap sebagai penyebab utama kes penyakit 
gastroenteritis akut yang berlaku secara epidemik dan berkala di seluruh dunia. 
Sehingga kini, tiada langkah intervensi terapeutik berlesen sama ada dari segi vaksin 
atau ubat-ubatan yang tersedia untuk mengawal penularan patogen manusia ini. 
Menyasarkan protein bukan struktural virus seperti protease adalah relevan kerana 
bahagian yang terjaga di samping fungsinya yang penting dalam sistem replikasi virus. 
Dalam kajian ini, versi mutasi MNV NS6 yang aktif (C139A NS6) telah diklon, 
diekspres dan ditulenkan sebelum digunakan dalam pendulangan bio / pemilihan yang 
menggunakan kit Ph.D-7TM Phage Display Peptide Library (NEB). Selepas 6 pusingan 
pendulangan bio, beberapa peptida faj yang spesifik dengan C139A NS6 telah 
berjaya dikenal pasti dan diasingkan. Peptida faj yang telah dikenalpasti kemudiannya 
telah disaring menggunakan pangkalan data peptida dalam talian dan hasilnya 
menunjukkan bahawa semua motif adalah unik dan tidak mempunyai persamaan 
dengan mana-mana peptida yang pernah diterbitkan. Spesifikasi ikatan beberapa klon 
peptida faj dengan jumlah pengulangan tertinggi telah diuji menggunakan ELISA. 
Keputusan ELISA menunjukkan klon yang membawa urutan peptida QTEKNPL 
mempunyai keupayaan mengikat yang tertinggi terhadap C139A NS6 berbanding 
klon lain dan juga klon kawalan. Dalam analisa silico, struktur tersier C139A NS6 
dan interaksi peptida terpilih (ADARYKS, QTEKNPL dan NSKLVLG) terhadap 
reseptor C139A NS6 telah diramal masing-masing menggunakan perisian I-
TASSER dan CABS-dock. Analisis dok menunjukkan bahawa semua urutan peptida 
xvii 
 
yang terpilih berinteraksi dengan reseptor C139A NS6 pada beberapa interaksi 
putatif. Menariknya, semua peptida yang dipilih mengikat reseptor C139A NS6 di 
tapak yang tiada dalam laporan penyelidikan sebelum ini. Analisis bioinformatik ini 
memberikan beberapa maklumat penting untuk penyelidikan pada masa hadapan 
berkaitan interaksi reseptor ligan yang melibatkan peptida terpilih dan protein 
C139A NS6. Maklumat ini berpotensi untuk dimanipulasi dalam pembangunan 
perencat peptida kecil terhadap protease NS6 serta untuk kegunaan diagnostik dengan 















IDENTIFICATION AND BINDING CHARACTERISATION OF PEPTIDE-
BEARING PHAGES TOWARDS RECOMBINANT PROTEASE (NS6) OF 





Norovirus infections are considered the most common causes of epidemic and 
sporadic cases of acute gastroenteritis worldwide. To date, there are no licensed 
therapeutic intervention measures either in terms of vaccines or drugs available for 
these highly contagious human pathogen. Targeting non-structural viral protein such 
as protease is relevant due to their well conserved regions along with its critical 
functions in viral replication. In this study, the active site mutant version of MNV NS6 
protease (C139A NS6) was cloned, overexpressed and purified before being used as 
target in biopanning/selection employing the Ph. D-7TM Phage Display Peptide Library 
kit (NEB) which was validated in streptavidin panning.  After six rounds of 
biopanning, several peptide phages that are specific towards C139A NS6 were 
isolated and identified successfully. Upon identification of peptide phage, the peptide 
sequences were screened using online peptide databases and results indicated that all 
the sequences were unique and did not possess common motif with any published 
peptides to date. Three peptide phage clones with highest number of hits were tested 
for their binding specificity towards purified C139A NS6 using ELISA. It was 
observed that clones carrying peptide sequence QTEKNPL had the highest binding 
affinity towards C139A NS6 as compared to other clones and irrelevant phage 
control. Tertiary structure of C139A NS6 and binding interaction of the selected 
peptides (ADARYKS, QTEKNPL and NSKLVLG) with C139A NS6 receptor were 
predicted using I-TASSER and CABS-dock software, respectively. Docking analysis 
xix 
 
showed that all the selected peptide sequences interact with C139A NS6 receptor at 
several contacts on the receptor binding sites that had never been published. This 
bioinformatics analysis uncovers some important information for future investigation 
in ligand-receptor interaction involving selected peptides and C139A NS6 protein 
which could potentially be manipulated in the development of small peptide inhibitor 
against NS6 protease as well as for the diagnostic purposes with ultimate purpose to 

















1.1 Research overview 
Virus is a small, infectious particle that can reproduce only by infecting a living cell 
and using its machinery to produce more viruses. They comprise of nucleic acid that 
can be either DNA or RNA which are enclosed in a protein shell called a capsid. Some 
viruses have an internal or external layer of membrane known as envelope. Virus are 
very diverse since they vary in their shapes, structures, kinds of genomes and type of 
hosts that they infect. Generally, viruses work by invading the host cells to make more 
copies of themselves and throughout the process, they often cause destruction to the 
invaded cell (Koonin, Senkevich, & Dolja, 2006).  
Noroviruses belong to the family of Caliciviridae are positive-sense, single-
stranded RNA virus. Due to their stability, low infectious dose, large host reservoir, 
short term immunity, multiple transmission routes and large diversity between strains, 
human norovirus particularly has been established as one of the leading causes that 
account for gastroenteritis cases worldwide with several clinical manifestations of 
acute diarrheal and vomiting, accompanied by several signs/symptoms like abdominal 
cramps, myalgia, malaise, headache, nausea and low-grade fever. This virus is thought 
to have a considerable economic impact due to the number of cases reported annually 
in developed countries.   
Despite complexity in the progress of the vaccines due to the high degree of 
genetic variation of this virus, there are few vaccines for human calicivirus that are 
under pre-clinical and clinical trial (Lucero, Vidal, & O'Ryan, 2017; Tan & Jiang, 
2014). Furthermore, immunity to human calicivirus is also short-lived since body are 
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not able to maintain immunity for a long time once a person is infected with natural 
infection (Mattison, 2011). For these reasons, antiviral therapy that is a class 
of treatment used specifically for treating viral infection seems to be an attractive 
strategy to allow the control of calicivirus outbreaks. An antiviral function by 
inhibiting the development of virus specifically by targeting the critical function of 
viral proteins, or parts of proteins which ultimately will affect the viral life cycle.  
Norovirus NS6 protease is an important enzyme that enables the activation of 
its other non-structural proteins. This protease acts as a key point for the activation of 
norovirus replication. The importance of the enzymatic activity of the NS6 protease 
through its main function in cleaving the chain of non-structural large polyproteins 
into several active proteins has made it as an attractive target for developing antiviral 
therapies. This could be achieved by inhibiting the function of this protease which may 
result in the inhibition of the cleavage process of non-structural proteins which 
subsequently disrupt the replication of the virus in infected host.  
Even though norovirus causes a huge lost to the western country and not widely 
spread in Malaysia, but due to current setting where immigration and emigration take 
place every single day, it is fair to take the possibilities of transmission of this virus 
into consideration. In this study, we aim to identify a peptide-bearing phages with the 
ability to bind the target (NS6) with high affinity and specificity using the phage 
display technique. After the identification of such peptide sequences, several 
commercial synthetic peptides could be synthesized and use to assess their inhibitory 
effects and efficiency to act as antiviral therapy. The benefit of developing peptide-
based antiviral drugs is that the peptides can be designed to mimic or interact with 
conserved surface proteins and in case of strains variety, the peptide sequence could 
be modified to preserve therapeutic efficiency. As compared to other approach, the 
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strength of peptide-based approach is in their good efficacy, safe, selectivity and 
predictable biocompatibility and biodegradability and are easy to being scaled-up. 
1.2 Objectives of Study 
1.2.1 General Objective 
This study was conducted to identify the peptide-bearing phages and characterise their 
binding ability towards recombinant protease (NS6) of murine norovirus (MNV).  
1.2.2 Specific Objectives 
1. To clone, express and purify mutant NS6 protease. 
2. To select peptide-bearing phage that binds to the recombinant mutant NS6 
protease. 
3. To determine the ability of the selected peptide-bearing phage to bind to the 
recombinant mutant NS6 protease. 
4. To predict the tertiary structure of mutant NS6 protease and docking analysis of 


















Gastroenteritis is a condition of an inflammation of gastrointestinal tract that includes 
stomach and intestinal mucosal surface (Schlossberg, 2015). It is also known as 
infectious diarrhea whereby it is associated with symptoms such as diarrhea, vomiting, 
malaise, muscle pain, fatigue, dehydration and high-grade fever  (Glass, Parashar, & 
Estes, 2009; Karst, 2010). This condition can be caused by infectious agents such as 
viruses (rotavirus and norovirus), bacteria (Escherichia coli and 
Campylobacter species), parasites (Giardia lamblia), fungus as well as non-infectious 
sources like medications and consumption of certain foods such as lactose and gluten 
(Ciccarelli, Stolfi, & Caramia, 2013; Helms & Quan, 2006; Szajewska & Dziechciarz, 
2010). However, the most common cause of gastroenteritis is due to infection by 
viruses; for example norovirus which causes 685 million cases and 213,515 death 
globally in developed and developing country (Pires et al., 2015).  
Virus that are commonly known to cause viral gastroenteritis are rotavirus, 
norovirus, adenovirus and astrovirus (Oude Munnink & van der Hoek, 2016). 
Rotavirus is the most known causes of gastroenteritis in children while norovirus has 
been identified as the major cause of epidemic gastroenteritis and common cause of 
diarrhea in adults (Glass et al., 2009; Hall et al., 2013). Initially in 1972, virus that was 
described as calicivirus was identified in the stool of patient with diarrhea during an 
outbreak of gastroenteritis in a school in Norwalk, Ohio (Kapikian, 2000; Kapikian et 
al., 1972). Currently, diarrheal disease is the top five causes of death worldwide with 
children are the most affected as compared to adult due to their lack of immunity 
development and relatively poor hygiene. In childhood gastroenteritis, norovirus have 
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been reported to be the second cause following rotavirus, but to date, the widespread 
use of vaccine against rotavirus has made norovirus to be more likely as the most 
common cause of gastroenteritis in childhood (Baehner, Bogaerts, & Goodwin, 2016; 
Karst, 2010) 
2.2 Caliciviruses 
The Caliciviridae family consists of small RNA viruses that are important in both 
medical and veterinary area (Royall & Locker, 2016). It belongs to Class IV of 
the Baltimore scheme where positive single-stranded RNA viruses whose mRNA is 
identical in base sequence to virion RNA can be accessed by host ribosomes to directly 
form proteins. Viruses with this type of RNA genome can be divided into two groups 
where both reproduce in the cytoplasm. The first group is polycistronic mRNA type 
viruses where mRNA from the genomic RNA is translated into a polyprotein. This 
product will then subsequently cleave to form single mature proteins. In contrast, the 
second group is where viruses with complex transcription use different mechanisms to 
produce proteins from the same strand of RNA. It can be either using subgenomic 
mRNAs, ribosomal frameshifting and proteolytic processing of polyprotein 
(Baltimore, 1971).  
The name calicivirus derived from the Latin word calyx which means cup 
or chalice; and being referred to 32 cup-shaped depressions on the surface of the entire 
virus particle arranged in icosahedral symmetry (Green et al., 2000; Prasad, Matson, 
& Smith, 1994). They are typically single-stranded and non-segmented, positive-sense 
RNA genome with size ranging from 6.7–8.5 kb (Black, Burroughs, Harris, & Brown, 
1978; Jiang, Wang, Wang, & Estes, 1993). The RNA genome of calicivirus were 
organised into two or three open reading frame (ORFs) flanked by two short 
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untranslated regions (Sosnovtsev et al., 2006). The genome structure in this family 
differs in the length of each ORF but they are all conserved. Major feature of 
Calicivirus is the absence of a methylated cap at the 5’ terminus of the virion RNA. 
Instead, a small protein (VPg) with size around 15 kDa was shown to be covalently 
linked to both 5’ end of the calicivirus genomic RNA (gRNA) and subgenomic RNA 
(sgRNA), with polyadenylated at the 3’ end. This VPg protein drives the initiation of 
translation and define to be essential for the infectivity of the RNA (Black et al., 1978; 
Burroughs & Brown, 1978). In addition, 3’ co-terminal sgRNA is also being 
transcribed during infection in all members of the Caliciviridae family (Royall & 
Locker, 2016). 
Caliciviruses infection are major cause of disease in humans and many animals 
as it can naturally infect organism such as human, cattle, cats and pigs (Hansman, 
Jiang, & Green, 2010). Previously, this virus is not very well studied since there is no 
suitable animal model and lack of efficient cell culture system. However, advancement 
in modern genomic technologies has led to an increased in understandings of the virus 
family. 
2.2.1 Classification and Taxonomy 
Caliciviruses are classified into five established genera that are Norovirus, Lagovirus, 
Vesivirus, Sapovirus and Nebovirus together with numbers of additional genera that 
have been proposed (Kitchen, Shackelton, & Holmes, 2011). They are Recovirus (eg, 
Tulane virus) for a novel calicivirus detected in stool specimens from rhesus 
macaques, Valovirus that represent a novel group of swine caliciviruses known as the 
St-Valérien-like viruses, Bavovirus that are found in chicken, 
Nacovirus and Bacovirus that contain novel caliciviruses recovered from chickens and 
turkeys respectively, Minovirus that infect farmed fathead minnows (Pimephales 
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promelas),  Salovirus that was identified in farmed Atlantic salmon (Salmo salar), 
Sanovirus was found in goose and also Secalivirus that was acquired from a sewage 
sample which consist of partial genome of a highly divergent calicivirus (Farkas, 
Sestak, Wei, & Jiang, 2008; L’Homme et al., 2009; Mikalsen et al., 2014; Mor et al., 
2017; Ng et al., 2012; Wang, Wang, Dong, Zhang, & Zhang, 2017; Wolf et al., 2012). 
Members of caliciviruses that causes acute gastroenteritis infections in human 
are norovirus and sapovirus while other members like lagovirus, vesivirus and 
becovirus/nebovirus are not pathogenic to humans (Bailey & Goodfellow, 2009). 
Initially, sapovirus was discovered in an outbreak of gastroenteritis in an orphanage 
in Sapporo, Japan (Chiba et al., 1979). This member of calicivirus is also known as 
“Sapporo-like viruses” includes Manchester Virus and porcine enteric calicivirus 
(PEC). The virus is transmitted through oral/fecal contact and most common 
symptoms are diarrhea and vomiting. The Vesivirus genus is circulating in swine, sea 
mammals, and felines as their natural hosts. This genus includes feline calicivirus and 
vesicular exanthema of swine virus; as well as San Miguel sea lion viruses that are 
found in marine and terrestrial mammals (Neill, Meyer, & Seal, 1995). Two main 
groups of Lagovirus are rabbit hemorrhagic disease virus that are highly fatal and 
European brown hare syndrome virus that was observed in the livers of infected hares 
in 1982 (Green et al., 2000). The genus Nebovirus contains two virus species that infect 
cattle are Newbury-1 virus and bovine enteric calicivirus NB (Nebraska). These 
viruses cause diarrhea and intestinal disease in calves (Oliver, Asobayire, Dastjerdi, & 
Bridger, 2006). 
2.2.2 Morphology and Genome Organisation of Caliciviruses 
In 1972, Albert Kapikian discovered a virion with 27 nm particle using immune-
electron microscope (Kapikian, 2000). The icosahedral structure of virus is described 
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as the first calicivirus virion and was popularly known as Norwalk virus. For 
Caliciviridae family, the viral genome acts as an mRNA template that can be readily 
translated, following entry into the infected cell. Members of these family have 
structure of gRNA that are conserved, however they differ in the length of each open 
reading frame (ORF). The Lagovirus, Sapovirus and Nebovirus genera have two ORFs 
while three distinct ORFs were observed for the Vesivirus and Norovirus genera 
(Rohayem et al., 2010). Meanwhile, murine noroviruses was found to carry a fourth 
ORF (McFadden et al., 2011) 
There are differences in term of the expression of structural proteins that are 
the major capsid protein (VP1) and minor capsid protein (VP2) among the genera. 
Within the Vesivirus and Norovirus genera, VP1 and VP2 are encoded by ORF2 and 
ORF3 from the sgRNA while in the Sapovirus, Lagovirus, and Nebovirus genera, both 
structural proteins are encoded by ORF1 and ORF2. The position of the VP1 coding 
region of the later genera is at the 3’ end of ORF1. The VP1 termination sequence are 
typically overlap with VP2 start codons and they can be separated by a short stretch 
around 3–10 nucleotides. Thus, this condition allows the translation of VP2 to take 
place through reinitiation process even though they are originated from single strand 
of mRNA (Royall & Locker, 2016) 
2.3 Norovirus 
History of norovirus started in 1929, where common childhood illness that causes 
vomiting, diarrhea and fever was detected and named as “winter vomiting disease” by 
Dr John Zahorsky who is a paediatrician (Zahorsky, 1929). In 1968, a virus is 
suspected when students and teachers of an elementary school in Norwalk, Ohio, 
experiences an outbreak of winter vomiting disease with symptoms of acute 
gastroenteritis, including vomiting and diarrhea (Adler & Zickl, 1969).  Several 
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experiments that was conducted to identify an etiology for this infectious form of acute 
gastroenteritis failed, until in 1972 where Dr. Albert Kapikian and his group 
successfully described the Norovirus prototype Norwalk virus found in stool samples 
using immune electron microscopy (Kapikian et al., 1972). Following the visualisation 
of the Norwalk virus particle, its genome was then cloned in 1990; led to the 
development of molecular tools to study noroviruses in more detail (Xi, Graham, 
Wang, & Estes, 1990) 
Noroviruses infection has been identified in various host that includes humans, 
swine, cattle, sheep, mice, cats and dogs (de Graaf et al., 2017). Human caliciviruses 
can cause infection in a population even at low infectious dose (Teunis et al., 2008). It 
is also known as winter vomiting disease as the infection/epidemics illustrate that it 
occurred typically during cold weather (Robilotti, Deresinski, & Pinsky, 2015). 
Norovirus outbreak mostly occur in semi-closed setting/environment communities that 
favour person-to-person transmission such as cruise ships, nursing homes, day care 
centres, schools, restaurants, hospitals, disaster relief/evacuation site, army barracks 
and even airplanes (Glass et al., 2009; Monroe, Ando, & Glass, 2000; Patel, Hall, 
Vinjé, & Parashar, 2009; Robilotti et al., 2015; Widdowson, Monroe, & Glass, 2005). 
The uncontrollable outbreak of norovirus infections is most likely due to high 
infectivity of norovirus particles, persistence of the virus in the environment, 
prolonged shedding of virus from both symptomatic and asymptomatic individuals and 
also short-term immunity (Kaufman, Green, & Korba, 2014). Norovirus is one of the 
genus under the Caliciviridae family that is considered as the most common cause of 
foodborne disease outbreak by Centers for Disesase Control and Prevention (CDC). It 
has been estimated that human pathogen within this genus cause at least 95% of 
nonbacterial gastroenteritis outbreaks and over 50% of all outbreaks worldwide (Karst, 
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2010). Thus, human norovirus (HuNv) is considered as a leading cause of 
gastroenteritis worldwide contributed to a severe economic burden to the health 
organisations of both the developed and developing world. This genus is highly 
transmissible primarily through exposure to contaminated food or water sources, 
person-to-person contact, an increased density of people, aerosolized vomitus particles 
and fomites (Karst, 2010; Lopman et al., 2012). They have been classified under 
Category B biodefense agents due to their characteristics that are highly contagious, 
extremely stable in the environment, resistant to common disinfectants and associated 
with debilitating illness. These conditions provide fundamental towards a fast 
spreading and highly contagious disease (Karst, 2010).  
 It is reported that person of all age groups is vulnerable towards norovirus 
infection and secondary infection are also common (Estes, Prasad, & Atmar, 2006). 
Norovirus replicate in gastrointestinal tracts of their host that result in acute or mild 
gastroenteritis characterised by symptoms such as vomiting and diarrhea coupled with 
or without nausea and abdominal cramp. Other symptoms include low-grade fever and 
malaise. There is also condition where the infected person is asymptomatic (Karst, 
2010). On the contrary, infection that occur in an immunocompromized mice (lacking 
components of the innate system) indicates that a broad tissue tropism was involved 
as MNV causes encephalitis, vasculitis, pneumonia and hepatitis (Karst, Wobus, Lay, 
Davidson, & Virgin, 2003).  
Replication of norovirus RNA genome is dependent on virus-encoded RNA-
dependent RNA polymerase, which has no proofreading activity that can correct the 
misincorporation of nucleotides during RNA synthesis. This condition results in high 
error-rate in genomic replication; causes the production of many progeny viruses with 
mutations. Therefore, norovirus is highly flexible and diversify as compared to other 
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RNA viruses (Estes et al., 2006; White, 2014). The Norovirus genus is classified based 
on phylogenetic clustering of the complete major capsid protein (VP1) amino acid 
sequence where members within a genogroup differ in their capsid genes by 45 -61%, 
while there are 14-44% and 0-14% different of members within genotype and strains 
within genotype respectively. These differences in term of intra-genus variation is high 
even compared to genera of other positive strand RNA virus families. High degree in 
genetic variation causes difficulty in developing protection against norovirus (Barclay 
et al., 2014; White, 2014; Zheng et al., 2006).  
Currently there are 7 genogroups for norovirus and each of them is further 
characterised into few genotypes (Robilotti et al., 2015; Zheng et al., 2006). The 
norovirus strains that infect humans and causes acute gastroenteritis are found in 32 
genotypes that are GI (n=9), GII (n=19) and GIV (n=1), whereas viruses in other 
genogroups infect other mammals. Noroviruses have also been isolated from other 
species including pigs (GII), bovine (GIII) and murine (GV) (Vinje, 2015). Recently 
proposed genogroups were GVI and GVII where norovirus was identified in domestic 
dogs with diarrhea (Mesquita, Barclay, Nascimento, & Vinjé, 2010). Among all the 
genogroups of norovirus, the GII.4 causes >80% of all human norovirus infections at 
any one time (Siebenga et al., 2009; White, 2014). This genotype virus is responsible 
for all six major norovirus pandemics of acute gastroenteritis in the last two decades 
(White, 2014). 
2.3.1 Norovirus Genome Structure 
Norovirus virion is non-enveloped with icosahedral symmetry of proteinaceous capsid 
that packages the RNA genome. The capsid is made up of 180 copies of the ORF2 
encoded protein, grouped as dimers in T=3 symmetry (Prasad, Hardy, Jiang, & Estes, 
1996; Prasad et al., 1999).  The linear single stranded positive sense RNA genome 
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with approximately 7.4–7.7 kb in size are typically organized into three open reading 
frames (ORF) (Figure 2.1A) (Jiang et al., 1993; Robilotti et al., 2015; Rocha-Pereira 
& Nascimento, 2012; Thorne & Goodfellow, 2014). Murine noroviruses possess a 
fourth ORF that is overlapping with ORF2 but in an alternate reading frame; and only 
some sapovirus members display an alternative open reading frame at the equivalent 
position (Clarke & Lambden, 2000; Thackray et al., 2007). All six of the nonstructural 
proteins of the norovirus genome are encoded in a single ORF (ORF1) at the 5’ end 
region while the 3’ end region is transcribed into a subgenomic information. The 
subgenomic region encodes the major and minor structural proteins in two separate 
ORFs that are ORF2 and ORF3 respectively (Karst, 2010).  
A study conducted by Prasad et al (1999) using Norwalk VLP revealed that 
major capsid protein (VP1) which determines the antigenicity of the virus are divided 
into three parts that are N-terminal, shell domain (S) located at the base of the capsid 
and a protruding (P) domain that is further subdivided into the P1 and P2 regions 
(Figure 2.1A and 2.1B). The P domain has ability to change shape that can result in its 
mutation due to its condition that is linked to the S domain by a flexible hinge region. 
The S domain provides internal core of the capsid while P domain probably contain 
both immune and cellular recognition sites. The interaction of inner S domain subunits 
with their neighbouring S domains form a continuous internal shell structure to the 
capsid. Meanwhile, the cup-like structure was formed when P domain emerge from 
the S domain surface (Hardy, 2005; Prasad et al., 1999). Mutational analysis on VLP 
results described that even though shell domain consist of components that are 
sufficient to initiate the assembly of capsid, the entire P domain is also important to 
enhance the stability and regulate the size of the capsid structure (Bertolotti-Ciarlet, 












Figure 2.1 A) Schematic representation of genome organization of Norovirus. The non-
structural protein is encoded in ORF1 while ORF2 and ORF3 encode for major and minor 
capsid protein respectively. There is presence of ORF4 that overlap with ORF2; only in 
murine norovirus. The VP1 (major capsid protein) is further characterised into domain. The 
small N-terminal domain (light blue) faces the interior of the particle. The shell domain (S) 
is colored blue. The P1 subdomains are colored red. The P2 domain (yellow) is an insertion 
in the P2 domain. The hypervariable region of VP1 is found in the P2 domain. B) The 
schematic structure of capsid protein from electron microscope based on description for 
ribbon in (A). The figure was adapted from (Lopman, 2015) 
Norovirus RNA genome is covalently linked with a viral protein (VPg) at their 
5’ ends and are polyadenlyated at their 3’ ends (Karst, 2010). Several conserved 
secondary structures that was important for the replication of a MNV was identified 
through bioinformatic analysis. These structures include two or more 5’ terminal stem-
loops, a 3’ terminal hairpin and a stem-loop just upstream of the ORF1/2 junction in 
the antigenomic strand proposed to be a component of the subgenomic promoter 
(Simmonds et al., 2008). 
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2.3.1(a) Norovirus Non-Structural Proteins 
Norovirus positive sense ssRNA genome is typically arranged into three ORFs and the 
genome layout is almost identical even though they are from different genogroups of 
norovirus.  The genomic and sgRNA of norovirus are uncapped and they are instead 
linked to a short viral protein (VPg) which act as a cap substitute at 5’ end followed 
by a short untranslated region (UTR) ranges from 3 and 5 nucleotides for human and 
murine norovirus respectively (Gutiérrez-Escolano, Brito, del Angel, & Jiang, 2000). 
The secondary structures of these UTRs play important roles in viral protein translation 
(McFadden et al., 2011). 
The ORF1, encodes a large polyprotein that comprises of all six mature non-
structural proteins (NS1-NS7), which is autocatalytically cleaved to produce 
individual non-structural proteins (Thorne & Goodfellow, 2014). The non-structural 
proteins were cleaved from polyprotein by the viral protease during and post-
translation; whereby the viral protease itself is catalytically an active component of the 
polyprotein (Hardy, 2005). These non-structural proteins are important for the 
establishment of viral replication complexes and genome replication. ORF2 encodes 
the major capsid protein (VP1) in an alternate reading frame from ORF1 while ORF3 
encodes for a minor structural protein (VP2). There are about 20 nucleotides 
overlapping between ORF1 and ORF2. Nevertheless, ORF2 is not co-translated with 
ORF1, but it is translated from a sgRNA covalently linked VPg-capped and 
polyadenylated that is produced during viral replication. ORF3 encodes protein in 
different reading frame than ORF2 (Thorne & Goodfellow, 2014). The ORF3 is 
proceed with 3’ UTR (forms secondary structures which function during initiation of 
viral protein translation) as well as the genome is polyadenylated at the 3’ end 
(McFadden et al., 2011; Rohayem, Robel, Jager, Scheffler, & Rudolph, 2006). 
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ORF1 that encode viral polyprotein which comprises of at least 6 individual 
protein subunits is the first protein translated following infection of a cell (Hardy, 
2005). The first non-structural protein in norovirus is NS1/2 or known as N-term, p48 
or ‘2B-like’ protein due to characteristic of this protein that have limited homology to 
picornavirus 2B protein. This protein carries similar function as picornavirus 2B that 
engage in rearrangement of membrane which lead to alteration of the membrane 
permeability (Fernandez-Vega et al., 2004). In addition, NS1/2 also interacts with a 
host protein necessitate in regulating vesicle transport and can inhibit cellular protein 
trafficking of cell surface expression (Ettayebi & Hardy, 2003). Other than that, 
expression of this 45 kDa protein using Norwalk virus showed that this protein is 
associated with Golgi disassembly suggesting their potential role in replication 
complex formation (Ettayebi & Hardy, 2003; Fernandez-Vega et al., 2004). According 
to Sosnovtsev et al. (2006) there is a presence of caspase cleavage site within the NS1/2 
of MNV, thus suggesting some cleavage during infection that probably associates virus 
replication to induction of program cell death.  
The second protein constituent of norovirus viral polyprotein is the nucleoside 
triphosphatase (NTPase), also referred to as p41. NS3 has been described to exhibit 
NTPase activity that act to bind and hydrolyse nucleotide triphosphate (Pfister & 
Wimmer, 2001). This protein shares sequence motifs with picornavirus protein 2C. 
Both proteins do not have helicase activity but unlike 2C, p41 is able to hydrolyse all 
NTPs instead of ATP only. According to a study conducted by Hyde et al. (2009) in 
MNV infected cells, NTPase showed that it plays a critical role in the establishment 
of viral replication complexes. 
The third protein component of the polyprotein is NS4, p22, or 3A-like protein 
as it is similar in gene order to the picornavirus 3A protein of picornavirus. VPg 
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recruitment to membranous replication complexes during replication is thought to be 
the function of NS4 (Wobus et al., 2004). Other than that, NS4 also may function in 
tissue culture adaptation of MNV since presence of sequence changes upon continuous 
passage of MNV-1 in RAW264.7 cells give rise to attenuated viruses (Bailey, 
Thackray, & Goodfellow, 2008).  
 The NS5 protein or VPg is covalently linked to the 5’ ends of viral gRNA and 
sgRNA of caliciviruses in place of a typical 5’ cap structure (Rohayem et al., 2006). It 
acts in a few roles in the viral life cycle but mainly it functions in translation initiation 
(Karst, 2010; Thorne & Goodfellow, 2014). During viral genome replication, the 
association of NS5 and RNA is thought to occur when NS5 is used as a peptide primer 
for genome replication by viral RNA-dependent RNA polymerase or RdRp (NS7). The 
uridylylation of VPg made it possible to act as primer during viral replication (Belliot, 
Sosnovtsev, Chang, McPhie, & Green, 2008; Rohayem et al., 2006). Biochemical 
analysis done in vitro performed by Rohayem et al (2006) confirmed the ability of 
norovirus NS7 to transfer nucleotide to NS5. Plus, there is study carried out by Guix 
et al (2007) stated that VPg that is covalently linked to 5’ end of human Norwalk virus 
RNA is important for virus infectivity. It is proven when MNV RNA generated from 
cDNA clone that is capped in vitro were found to be infectious when transfected into 
cell (Yunus, Chung, Chaudhry, Bailey, & Goodfellow, 2010). Other than that, there is 
also an interaction between VPg and host translation initiation factors take place; 
probably to recruit them to the 5’ end of the RNA genome for translation initiation of 
virus (Karst, 2010). 
 Norovirus ORF1 encodes for a large polyprotein that is post-translationally 
cleaved by the virus-encoded 3C-like protease (NS6) (Blakeney, Cahill, & Reilly, 
2003; Sosnovtsev et al., 2006). Even though it is part of the ORF1 polyprotein, the 
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NS6 is able to be released first from the polyprotein by autocatalytic cleavage then 
followed by specific cleavage of other proteins from ORF1. This 19 kDa protein is 
thought to play a role in inhibition of cellular protein synthesis in infected cell. NS6 
also able to cleave poly A-binding protein and host cell protein named as elF4G; both 
were necessary for mRNA translation of host cell (Kuyumcu-Martinez et al., 2004; 
Willcocks, Carter, & Roberts, 2004). This protein will be discussed in more detail in 
later Section 2.3.4. 
The NS7 protein or can be referred as 3Dpol encodes for viral RNA-dependent 
RNA polymerase (RdRp) or also known as RNA replicase is an important enzyme for 
gRNA and sgRNA viral replicaton as it functions in catalysing the synthesis of RNA 
from RNA template. This protein that is positioned at C-terminus of norovirus non-
structural polyprotein also possess a typical right-handed conformation (palm, fingers 
and thumb) shared by all positive-sense RNA viruses (Ferrer-Orta, Arias, Escarmís, & 
Verdaguer, 2006). There are four main mechanisms in which recombinant calicivirus 
RdRp have been demonstrated to initiate RNA synthesis. The mechanisms include a 
de novo initiation and primer-independent initiation, back-priming base initiation and 
a protein-primed initiation via VPg nucleotidylylation (Rohayem et al., 2006). 
2.3.1(b) Norovirus Structural Proteins 
Norovirus ORF2 and ORF3 encodes the major and minor structural protein 
respectively. Both structural proteins are expressed from the viral VPg-linked sgRNA 
that is 3’ co-terminal with the gRNA and polyadenylated.  
Norovirus ORF2 contain 58.9 kDa major structural protein VP1 or capsid. 
Independent expression of VP1 from other viral components results in formation of 
dimer that can lead to the self-assembly of VLPs (Jiang, Wang, Graham, & Estes, 
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1992). These structures are morphologically and antigenically exhibit the same 
properties of native norovirus virions and have been remarkably useful to study a 
variety of virus-host interactions in the absence of a cell culture system (Jiang et al., 
2000). The P2 domain of VP1 consist of a hypervariable region that is suspected to 
have receptor binding and antigenic sites; consistent with its exposed location on the 
virion surface. Study conducted by Bailey et al (2008) showed that in vivo attenuation 
is observed when a single amino acid is changed in the P2 domain of MNV (Bailey et 
al., 2008; Wobus et al., 2004). 
Minor structural protein or VP2 is encoded by norovirus ORF3 and it is present 
in only 1–2 copies per virion (Glass et al., 2000; Karst, 2010). Among the virus within 
Caliciviridae family, VP2 is small, basic, and quite divergent in both size and 
sequence. VP2 is thought to increases the expression level of VP1 and also stabilisation 
of capsid (Bertolotti-Ciarlet, Crawford, Hutson, & Estes, 2003). Its role in viral 
replication is currently undefined but there is evidence that VP2 is essential for 
production of infectious particle and for viral replication in feline calicivirus 
(Sosnovtsev, Belliot, Chang, Onwudiwe, & Green, 2005). Moreover, the basic charge 
of VP2 indicates that it may be responsible in encapsidation of the viral genome. The 
expression of VP1 is speculating to occur via VPg-directed translation initiation which 
is similar to expression of non-structural proteins from gRNA while VP2 proceeds via 
a translation termination re-initiation (TTR) mechanism (Karst, 2010). 
 Fourth ORF was found in MNV where it overlapped with VP1 coding region 
and encodes for virulence factor 1 (VF1) (McFadden et al., 2011).  
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2.3.2 Virus Life Cycle 
Previously, knowledge on norovirus pathogenesis are limited and primarily based on 
physical, histological and biochemical studies conducted on infected human volunteer. 
Investigation and progression study on its biological aspect has been very slow due to 
lack of efficient cell culture system and absence of animal model system. However, in 
2003, MNV has been discovered as biological model system to study norovirus since 
it was able to replicate efficiently in tissue culture and also due to establishment of 
reverse genetics system based on the first isolated strain from MNV (Chaudhry, 
Skinner, & Goodfellow, 2007; Karst et al., 2003; Ward et al., 2007; Wobus et al., 2004; 
Yunus et al., 2010). The discovery of excellent model system allowed investigation 
and analysis of the norovirus’ infectivity and pathogenesis in vivo. Even though some 
aspects of MNV such as the disease manifestation does not apply to human norovirus, 
but this model is the only readily available system which could contribute to 
understand norovirus translation, replication and its pathogenesis. 
2.3.2(a) Attachment and Entry 
The life cycle of norovirus begins when there is interaction of virus with its receptor 
on the cell surface of the host which is known to involve carbohydrate structures such 
as histo blood group antigen (HBGAs) in human norovirus cases (Donaldson, 
Lindesmith, LoBue, & Baric, 2010). The susceptibility of individual towards norovirus 
infection is determined by the secretor status of the H antigen (Hutson, Airaud, 
LePendu, Estes, & Atmar, 2005). Study conducted by Thorven et al. (2005) showed 
that individuals who are non-secretors of H-type 1 were found to be resistant to 
norovirus infection. The absent of H type secretion is due to mutation in the α-(1,2)-
fucosyltransferace (FUT2) gene that is involve in the production of H-type 1 antigen 
in saliva and mucosa. On the other hand, study performed on MNV indicated that the 
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attachment receptor that is bind in the strain dependent manner of the host cells is 
through ganglioside-linked terminal sialic acid moieties, glycolipids and glycoproteins 
(Taube et al., 2012; Taube et al., 2009).  Once bound to its receptor, MNV enters cell 
by which the mechanism remains unclear. However, it is found out that the method of 
MNV entry into the host cell is dependent on dynamin and cholesterol instead of 
clathrin and caveolin like feline calicivirus (FCV) (Gerondopoulos, Jackson, 
Monaghan, Doyle, & Roberts, 2010; Stuart & Brown, 2006). This is because study 
conducted for MNV is by using RAW264.7 where it did not express caveolin and also 
there is no reduction in MNV infectivity when there is interfering in the clathrin 
pathway. Unlike FCV, flotillin depletion and endosomal acidification blockers also 
did not cause reduction in MNV infectivity. Cholesterol and dynamin pathways is 
thought to be the method of virus entry due to reduction in MNV infectivity post 
treatment with methyl-beta-cyclodextrin and dynamin inhibitor; even though the 
reduction is observed only when the cells is treated before and not after infection 
(Gerondopoulos et al., 2010).  
2.3.2(b) Translation of Viral Proteins 
After entry on the positive sense VPg-linked RNA genome into the cytoplasm of the 
permissive cell, it can immediately act as an mRNA template for initial round of viral 
RNA translation.  Protein synthesis takes place upon recognition of viral RNA by 
cellular translation initiation factors first, before they are being translated into protein 
by cellular translation apparatus. Translation of viral gRNA typically use novel 
mechanism involving VPg to initiate translation and to increase coding capacity of 
their relatively short genome (Firth & Brierley, 2012; Thorne & Goodfellow, 2014). 
The VPg which is the viral protein genome linked is a non-structural protein that is 
covalently linked to the 5’ end of the gRNA and sgRNA where they mediate translation 
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process to produce viral protein. It also serves as a cap substitute to ensure that its 
RNA is translated instead of host cell mRNA which constitute of classical 5’ cap 
structure (Bailey & Goodfellow, 2009; Thorne & Goodfellow, 2014). Recently, study 
conducted by Leen et al. (2013) provided information that virus-encoded VPg protein 
possessed a compact helical core flanked by intrinsically flexible disordered N- and 
C- terminus. These flexibilities might aid to the numerous roles carried by VPg in 
norovirus life cycle (Goodfellow, 2011). 
The VPg protein also play a role in the interaction with the component of elF4F 
host cell translation initiation factor complex. The translation initiation machinery 
includes cap binding protein (elF4E), a scaffold protein (elF4G) that link the elF4F 
complex to the elF3 and RNA helicase (elF4A). The Vpg protein bind to the cap 
binding of elF4F component and this interaction result in recruitment of elF4G 
scaffold. Recruitment of RNA helicase component elF4A and elF3 complex is enabled 
following binding of elF4G and elF4E. After that, 43S ribosomal pre-initiation 
complex is recruited to the complex by elF3 prior to translation initiation (Chaudhry 
et al., 2006; Daughenbaugh, Fraser, Hershey, & Hardy, 2003; Goodfellow et al., 2005). 
The 43S pre-initiation complex is formed upon the interaction of the Met-tRNAiMet-
elF2-GTP and 40S ribosomal subunit is stabilized by elF3 (Putics, Vashist, Bailey, & 
Goodfellow, 2010).  Although Vpg is observed to bind with elF4E of both MNV and 
FCV, but its interaction is crucial only in FCV. This is because inhibition in the elF4E 
activity of FCV show that it severey affect the Vpg linked RNA of FCV but not the in 
vitro translation of MNV Vpg linked RNA (Chaudhry et al., 2006).  
 The viral genome translation process will result in the production of proteins 
where each carry an essential role for viral replication. The first open reading frame 
encode for non-structural protein that is translated in a form of large polyprotein. This 
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polyprotein is then co- and post-translationally cleaved by the viral encoded protease 
at five specific junctions; releasing six mature forms of non-structural proteins 
(Blakeney et al., 2003; Liu, Viljoen, Clarke, & Lambden, 1999). Research performed 
by Sosnovtsev et al. (2006, 2002) stated that these proteins able to carry out their 
function in their separate form as compared to FCV in which their protease and 
polymerase is in the fusion form named p76. On the other hand, ORF2 and ORF3 
encode for VP1 (major) and VP2 (minor) capsid protein respectively. These proteins 
are part of sgRNA where in the infected cell, they are found to be in higher levels as 
compared to gRNA (Prasad, Rothnagel, Jiang, & Estes, 1994). Moreover, it is common 
for positive sense RNA viruses to produce sgRNA during the viral life cycle in order 
for them to control the viral protein expression. In addition to that, norovirus exhibit a 
polycistronic subgenomic that require a process to ensure that ribosomes are able to 
bind and translate the open reading frames that are located downstream. Hence, 
termination-reinitiation process is used with the aid of overlapping start and stop codon 
in between the ORF segment to allow expression of products from adjacent ORFs. In 
this process, the upstream ORF is translated by ribosome until it reaches stop codon at 
the end of its ORF. After that, the proportion of the ribosomal subunit that remain 
associated to the mRNA was reinitiated to translate downstream ORF at the start codon 
of the respective ORF (Napthine et al., 2009).  
As mentioned previously, MNV exhibit the fourth ORF that is overlapped with 
VP1, known as virulence factor 1 (VF1). This VF1 is antagonist to the innate immune 
response since protein express from ORF4 slow down the upregulation gene activated 
by the innate pathway. In comparison to the position of ORF2, this sgRNA VF1 started 
13 bases downstream and it is possibly initiated by leaky scanning and two slips in the 
ribosome. Reverse genetic study indicated that this protein is not required for 
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replication in tissue culture and indeed only function as a viral accessory protein 
(McFadden et al., 2011). 
2.3.2(c) Genome Replication 
The expression of viral non-structural protein lead to the formation of cytoplasmic 
membrane-bound replication complexes; thus allowing the replication process of viral 
genome (Bailey & Goodfellow, 2009). The replication complex is thought to act as the 
surface for the assembly of both viral and cellular replication factor where it also 
comprises of a few components that are essential for viral replication such as viral 
RdRp, viral RNA (single and double stranded intermediates), other viral enzymes as 
well as host cell factors. The replication for all positive strand RNA viruses requires 
genome to function as mRNA for production of viral protein needed for genome 
replication and as a template for negative strand RNA synthesis (Thorne & 
Goodfellow, 2014). 
The RNA synthesis takes place following the interaction of RdRp with other viral 
and cellular factors which enable it to bind at the promoter sequence located 3’ end of 
both strand of RNA. Since norovirus viral genome RNA is in the form of positive 
strand, it can directly be used as the template to generate negative strand RNA by de 
novo initiation. The produced negative sense RNA is then subsequently used for the 
production of higher levels of positive strand gRNA and sgRNA. The production of 
sgRNA is the unique characteristic possess by all caliciviruses during their replication 
in infected cells. The sgRNA is attach to Vpg at the 5’end and polyadenylated at the 
3’ end. They are expressed at the 3’ co-terminal of the full-length gRNA. The sgRNA 
of caliciviruses consist of ORF2 and ORF3 (and ORF4 for MNV) which encode for 
viral structural proteins. There are two proposed mechanism for production of sgRNA 
where both use negative sense RNA intermediate and RdRp encoded by NS7 gene in 
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ORF1 (Karst, 2010; Putics et al., 2010; Royall & Locker, 2016). Plus, norovirus RdRp 
exhibit an active site residues that is structurally and functionally conserved as other 
positive strand RNA viruses RdRp (Högbom, Jäger, Robel, Unge, & Rohayem, 2009). 
The first mechanism involves premature termination during the synthesis of 
negative-sense gRNA. The NS7 RdRp terminates during elongation upon reaching 
termination signal that is located upstream of VP1 coding region, generating negative 
sense of subgenomic strand. The negative strand is then used as a template for VPg-
dependent RNA synthesis to produce positive sense sgRNA; arising from de novo 
initiation. The replication of sgRNA will be repeated and eventually packed using VP1 
capsid protein to form new virus particle. The model also proposed that higher 
production of positive sense viral RNA as indicated by increasing level of VP1 would 
lead to the formation of multimeric complexes by VP1 in order to prevent its 
interaction with RdRp. These result in the capsid assembly and consequently the 
formation of new infectious viral particles (Putics et al., 2010; Thorne & Goodfellow, 
2014).  
The second mechanism for sgRNA synthesis known as internal initiation involved 
a presence of secondary structure upstream of ORF2 in the negative sense gRNA 
where it serves as the promoter to generate positive-sense sgRNA. The RdRp will 
initiate RNA synthesis following VPg-dependent fashion to produce new strand of 
sgRNA strand. Sufficient sgRNA is further encapsidated to produce new viral particle 
(Thorne & Goodfellow, 2014). Bioinformatic study conducted by Simmonds et al. 
(2008) in among all the members of Caliciviridae family found out the presence of 
highly conserved RNA stem loop structure located downstream of VP1 coding region 
on the negative sense gRNA. The structure that is positioned 6 nucleotide (nt) from 
the start of the sgRNA is confirmed for its accuracy by the genetic and biochemical 
